Earth Science Tech, Inc. (OTC: ETST) reported financial and operational results for the third fiscal quarter ended December 31, 2025, highlighting significant growth in revenue and profitability. The company posted revenue of $8.4 million, a 14.1% increase compared to the same period last year. Gross profit reached $6.4 million, reflecting a robust margin of 76.3%. Net income surged to $910,000, up 341% from the prior-year period, while adjusted EBITDA totaled $1.2 million. These results underscore the company's improving operational efficiency and successful expansion initiatives.
Total assets increased to $8.1 million, and the company ended the quarter with $416,000 in cash and $773,000 in working capital, with no bank debt. Management attributed the strong performance to continued operating leverage and strategic investments in its core business segments. During the first nine months of fiscal 2026, Earth Science Tech repurchased and retired 3.7 million shares, signaling confidence in its financial position and future prospects.
The company operates as a strategic holding company focused on value creation through acquisition, operational optimization, and management of its operating businesses. Its subsidiaries include RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef. These entities span compounding pharmaceuticals, telemedicine, and real estate development, providing diversified revenue streams.
The results come as the company looks ahead to calendar 2026 with expansion plans. The notable increase in net income and EBITDA highlights the effectiveness of its cost management and growth strategies. Investors and stakeholders can find the latest news and updates relating to ETST in the company’s newsroom at https://ibn.fm/ETST. The full press release is available at https://ibn.fm/emIBm.
Earth Science Tech's strong quarterly performance indicates that its diversified business model and disciplined capital allocation are yielding tangible results. The company's ability to generate high gross margins and substantial net income growth positions it favorably in the competitive landscape of healthcare and real estate development. With no bank debt and a solid working capital position, Earth Science Tech appears well-equipped to pursue further growth opportunities.
